Gleiss Lutz focuses on patent disputes in the pharmaceutical and automotive sectors, supplemented by expertise in SEP and FRAND-related issues. In addition to its presence before the UPC, which has existed since 2023, the practice has recently also handled first AI-related disputes. Practice head Matthias Sonntag's areas of expertise include medical devices and electronics, while he complements his forensic expertise with experience in licensing and technology transfer. Thomas Bopp retired at the end of 2024.
Legal 500 Editorial commentary
Key clients
- Alfred Kärcher SE & Co. KG
- ANDREAS STIHL AG & Co. KG
- Bosch Rexroth (UK)
- Hexal
- Karl Storz GmbH & Co.KG
- Luye Pharma
- Procter & Gamble
- Sagemcom
- Sony
- Supponor
Work highlights
- Successful representation of Supponor in a patent dispute in Germany and before the Unified Patent Court regarding “digital overlay technology” for the live broadcast of sporting events (e.g. Bundesliga).
- Successful representation of Hexal in the patent dispute concerning a DMF generic for the MS drug Tecfidera.
- Successfully represented Procter & Gamble in a multi-patent dispute, including a vindication proceeding, concerning AI-based motion pattern recognition.
Practice head
The lawyer(s) leading their teams.
Matthias Sonntag